228 related articles for article (PubMed ID: 26743380)
21. mTOR pathway candidate genes and physical activity interaction on breast cancer risk in black women from the women's circle of health study.
Ilozumba MN; Yaghjyan L; Datta S; Zhao J; Gong Z; Hong CC; Lunetta KL; Zirpoli G; Bandera EV; Palmer JR; Yao S; Ambrosone CB; Cheng TD
Breast Cancer Res Treat; 2023 May; 199(1):137-146. PubMed ID: 36882608
[TBL] [Abstract][Full Text] [Related]
22. Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study.
Teraoka SN; Bernstein JL; Reiner AS; Haile RW; Bernstein L; Lynch CF; Malone KE; Stovall M; Capanu M; Liang X; Smith SA; Mychaleckyj J; Hou X; Mellemkjaer L; Boice JD; Siniard A; Duggan D; Thomas DC; ; Concannon P
Breast Cancer Res; 2011; 13(6):R114. PubMed ID: 22087758
[TBL] [Abstract][Full Text] [Related]
23. FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation.
Udler MS; Meyer KB; Pooley KA; Karlins E; Struewing JP; Zhang J; Doody DR; MacArthur S; Tyrer J; Pharoah PD; Luben R; Bernstein L; Kolonel LN; Henderson BE; Le Marchand L; Ursin G; Press MF; Brennan P; Sangrajrang S; Gaborieau V; Odefrey F; Shen CY; Wu PE; Wang HC; Kang D; Yoo KY; Noh DY; Ahn SH; Ponder BA; Haiman CA; Malone KE; Dunning AM; Ostrander EA; Easton DF;
Hum Mol Genet; 2009 May; 18(9):1692-703. PubMed ID: 19223389
[TBL] [Abstract][Full Text] [Related]
24. Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER
Mao P; Cohen O; Kowalski KJ; Kusiel JG; Buendia-Buendia JE; Cuoco MS; Exman P; Wander SA; Waks AG; Nayar U; Chung J; Freeman S; Rozenblatt-Rosen O; Miller VA; Piccioni F; Root DE; Regev A; Winer EP; Lin NU; Wagle N
Clin Cancer Res; 2020 Nov; 26(22):5974-5989. PubMed ID: 32723837
[TBL] [Abstract][Full Text] [Related]
25. Incidence of breast cancer and its subtypes in relation to individual and multiple low-penetrance genetic susceptibility loci.
Reeves GK; Travis RC; Green J; Bull D; Tipper S; Baker K; Beral V; Peto R; Bell J; Zelenika D; Lathrop M;
JAMA; 2010 Jul; 304(4):426-34. PubMed ID: 20664043
[TBL] [Abstract][Full Text] [Related]
26. Single nucleotide variants in metastasis-related genes are associated with breast cancer risk, by lymph node involvement and estrogen receptor status, in women with European and African ancestry.
Roberts MR; Sucheston-Campbell LE; Zirpoli GR; Higgins M; Freudenheim JL; Bandera EV; Ambrosone CB; Yao S
Mol Carcinog; 2017 Mar; 56(3):1000-1009. PubMed ID: 27597141
[TBL] [Abstract][Full Text] [Related]
27. Genetic variants in one-carbon metabolism genes and breast cancer risk in European American and African American women.
Gong Z; Yao S; Zirpoli G; David Cheng TY; Roberts M; Khoury T; Ciupak G; Davis W; Pawlish K; Jandorf L; Bovbjerg DH; Bandera EV; Ambrosone CB
Int J Cancer; 2015 Aug; 137(3):666-77. PubMed ID: 25598430
[TBL] [Abstract][Full Text] [Related]
28. Genetic variants on chromosome 5p12 are associated with risk of breast cancer in African American women: the Black Women's Health Study.
Ruiz-Narvaez EA; Rosenberg L; Rotimi CN; Cupples LA; Boggs DA; Adeyemo A; Cozier YC; Adams-Campbell LL; Palmer JR
Breast Cancer Res Treat; 2010 Sep; 123(2):525-30. PubMed ID: 20140701
[TBL] [Abstract][Full Text] [Related]
29. A survey of microRNA single nucleotide polymorphisms identifies novel breast cancer susceptibility loci in a case-control, population-based study of African-American women.
Bensen JT; Graff M; Young KL; Sethupathy P; Parker J; Pecot CV; Currin K; Haddad SA; Ruiz-Narváez EA; Haiman CA; Hong CC; Sucheston-Campbell LE; Zhu Q; Liu S; Yao S; Bandera EV; Rosenberg L; Lunetta KL; Ambrosone CB; Palmer JR; Troester MA; Olshan AF
Breast Cancer Res; 2018 Jun; 20(1):45. PubMed ID: 29871690
[TBL] [Abstract][Full Text] [Related]
30. Fine-mapping of the 6q25 locus identifies a novel SNP associated with breast cancer risk in African-American women.
Ruiz-Narváez EA; Rosenberg L; Yao S; Rotimi CN; Cupples AL; Bandera EV; Ambrosone CB; Adams-Campbell LL; Palmer JR
Carcinogenesis; 2013 Feb; 34(2):287-91. PubMed ID: 23104177
[TBL] [Abstract][Full Text] [Related]
31. GWAS in the SIGNAL/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patients.
Cox DG; Curtit E; Romieu G; Fumoleau P; Rios M; Bonnefoi H; Bachelot T; Soulié P; Jouannaud C; Bourgeois H; Petit T; Tennevet I; Assouline D; Mathieu MC; Jacquin JP; Lavau-Denes S; Darut-Jouve A; Ferrero JM; Tarpin C; Lévy C; Delecroix V; Trillet-Lenoir V; Cojocarasu O; Meunier J; Pierga JY; Faure-Mercier C; Blanché H; Sahbatou M; Boland A; Bacq D; Besse C; Deleuze JF; Pauporté I; Thomas G; Pivot X
Oncotarget; 2016 Nov; 7(47):77358-77364. PubMed ID: 27764800
[TBL] [Abstract][Full Text] [Related]
32. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation.
Ghoussaini M; French JD; Michailidou K; Nord S; Beesley J; Canisus S; Hillman KM; Kaufmann S; Sivakumaran H; Moradi Marjaneh M; Lee JS; Dennis J; Bolla MK; Wang Q; Dicks E; Milne RL; Hopper JL; Southey MC; Schmidt MK; Broeks A; Muir K; Lophatananon A; Fasching PA; Beckmann MW; Fletcher O; Johnson N; Sawyer EJ; Tomlinson I; Burwinkel B; Marme F; Guénel P; Truong T; Bojesen SE; Flyger H; Benitez J; González-Neira A; Alonso MR; Pita G; Neuhausen SL; Anton-Culver H; Brenner H; Arndt V; Meindl A; Schmutzler RK; Brauch H; Hamann U; Tessier DC; Vincent D; Nevanlinna H; Khan S; Matsuo K; Ito H; Dörk T; Bogdanova NV; Lindblom A; Margolin S; Mannermaa A; Kosma VM; ; Wu AH; Van Den Berg D; Lambrechts D; Floris G; Chang-Claude J; Rudolph A; Radice P; Barile M; Couch FJ; Hallberg E; Giles GG; Haiman CA; Le Marchand L; Goldberg MS; Teo SH; Yip CH; Borresen-Dale AL; ; Zheng W; Cai Q; Winqvist R; Pylkäs K; Andrulis IL; Devilee P; Tollenaar RA; García-Closas M; Figueroa J; Hall P; Czene K; Brand JS; Darabi H; Eriksson M; Hooning MJ; Koppert LB; Li J; Shu XO; Zheng Y; Cox A; Cross SS; Shah M; Rhenius V; Choi JY; Kang D; Hartman M; Chia KS; Kabisch M; Torres D; Luccarini C; Conroy DM; Jakubowska A; Lubinski J; Sangrajrang S; Brennan P; Olswold C; Slager S; Shen CY; Hou MF; Swerdlow A; Schoemaker MJ; Simard J; Pharoah PD; Kristensen V; Chenevix-Trench G; Easton DF; Dunning AM; Edwards SL
Am J Hum Genet; 2016 Oct; 99(4):903-911. PubMed ID: 27640304
[TBL] [Abstract][Full Text] [Related]
33. Heterogeneity of Breast Cancer Associations with Common Genetic Variants in FGFR2 according to the Intrinsic Subtypes in Southern Han Chinese Women.
Liang H; Yang X; Chen L; Li H; Zhu A; Sun M; Wang H; Li M
Biomed Res Int; 2015; 2015():626948. PubMed ID: 26421298
[TBL] [Abstract][Full Text] [Related]
34. A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.
Siddiq A; Couch FJ; Chen GK; Lindström S; Eccles D; Millikan RC; Michailidou K; Stram DO; Beckmann L; Rhie SK; Ambrosone CB; Aittomäki K; Amiano P; Apicella C; ; Baglietto L; Bandera EV; Beckmann MW; Berg CD; Bernstein L; Blomqvist C; Brauch H; Brinton L; Bui QM; Buring JE; Buys SS; Campa D; Carpenter JE; Chasman DI; Chang-Claude J; Chen C; Clavel-Chapelon F; Cox A; Cross SS; Czene K; Deming SL; Diasio RB; Diver WR; Dunning AM; Durcan L; Ekici AB; Fasching PA; ; Feigelson HS; Fejerman L; Figueroa JD; Fletcher O; Flesch-Janys D; Gaudet MM; ; Gerty SM; Rodriguez-Gil JL; Giles GG; van Gils CH; Godwin AK; Graham N; Greco D; Hall P; Hankinson SE; Hartmann A; Hein R; Heinz J; Hoover RN; Hopper JL; Hu JJ; Huntsman S; Ingles SA; Irwanto A; Isaacs C; Jacobs KB; John EM; Justenhoven C; Kaaks R; Kolonel LN; Coetzee GA; Lathrop M; Le Marchand L; Lee AM; Lee IM; Lesnick T; Lichtner P; Liu J; Lund E; Makalic E; Martin NG; McLean CA; Meijers-Heijboer H; Meindl A; Miron P; Monroe KR; Montgomery GW; Müller-Myhsok B; Nickels S; Nyante SJ; Olswold C; Overvad K; Palli D; Park DJ; Palmer JR; Pathak H; Peto J; Pharoah P; Rahman N; Rivadeneira F; Schmidt DF; Schmutzler RK; Slager S; Southey MC; Stevens KN; Sinn HP; Press MF; Ross E; Riboli E; Ridker PM; Schumacher FR; Severi G; Dos Santos Silva I; Stone J; Sund M; Tapper WJ; Thun MJ; Travis RC; Turnbull C; Uitterlinden AG; Waisfisz Q; Wang X; Wang Z; Weaver J; Schulz-Wendtland R; Wilkens LR; Van Den Berg D; Zheng W; Ziegler RG; Ziv E; Nevanlinna H; Easton DF; Hunter DJ; Henderson BE; Chanock SJ; Garcia-Closas M; Kraft P; Haiman CA; Vachon CM
Hum Mol Genet; 2012 Dec; 21(24):5373-84. PubMed ID: 22976474
[TBL] [Abstract][Full Text] [Related]
35. Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study.
Yao S; Zirpoli G; Bovbjerg DH; Jandorf L; Hong CC; Zhao H; Sucheston LE; Tang L; Roberts M; Ciupak G; Davis W; Hwang H; Johnson CS; Trump DL; McCann SE; Ademuyiwa F; Pawlish KS; Bandera EV; Ambrosone CB
Breast Cancer Res; 2012 Apr; 14(2):R58. PubMed ID: 22480149
[TBL] [Abstract][Full Text] [Related]
36. Genetic variants in the mTOR pathway and interaction with body size and weight gain on breast cancer risk in African-American and European American women.
Cheng TY; Shankar J; Zirpoli G; Roberts MR; Hong CC; Bandera EV; Ambrosone CB; Yao S
Cancer Causes Control; 2016 Aug; 27(8):965-76. PubMed ID: 27314662
[TBL] [Abstract][Full Text] [Related]
37. Breast cancer risk associated with genotypic polymorphism of the genes involved in the estrogen-receptor-signaling pathway: a multigenic study on cancer susceptibility.
Yu JC; Hsu HM; Chen ST; Hsu GC; Huang CS; Hou MF; Fu YP; Cheng TC; Wu PE; Shen CY
J Biomed Sci; 2006 May; 13(3):419-32. PubMed ID: 16502042
[TBL] [Abstract][Full Text] [Related]
38. A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort.
Lee SA; Haiman CA; Burtt NP; Pooler LC; Cheng I; Kolonel LN; Pike MC; Altshuler D; Hirschhorn JN; Henderson BE; Stram DO
BMC Med Genet; 2007 Dec; 8():72. PubMed ID: 18053149
[TBL] [Abstract][Full Text] [Related]
39. Enhanced statistical tests for GWAS in admixed populations: assessment using African Americans from CARe and a Breast Cancer Consortium.
Pasaniuc B; Zaitlen N; Lettre G; Chen GK; Tandon A; Kao WH; Ruczinski I; Fornage M; Siscovick DS; Zhu X; Larkin E; Lange LA; Cupples LA; Yang Q; Akylbekova EL; Musani SK; Divers J; Mychaleckyj J; Li M; Papanicolaou GJ; Millikan RC; Ambrosone CB; John EM; Bernstein L; Zheng W; Hu JJ; Ziegler RG; Nyante SJ; Bandera EV; Ingles SA; Press MF; Chanock SJ; Deming SL; Rodriguez-Gil JL; Palmer CD; Buxbaum S; Ekunwe L; Hirschhorn JN; Henderson BE; Myers S; Haiman CA; Reich D; Patterson N; Wilson JG; Price AL
PLoS Genet; 2011 Apr; 7(4):e1001371. PubMed ID: 21541012
[TBL] [Abstract][Full Text] [Related]
40. FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women.
Barnholtz-Sloan JS; Shetty PB; Guan X; Nyante SJ; Luo J; Brennan DJ; Millikan RC
Carcinogenesis; 2010 Aug; 31(8):1417-23. PubMed ID: 20554749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
